Characteristics of patients with PsA (n = 480) | |
Female gender, n (%) | 275 (57) |
Plaque psoriasis, n (%) | 393 (82) |
Type I psoriasis (age at onset ⩽40 years), n (%) | 354 (74) |
Type II psoriasis (age at onset >40 years), n (%) | 123 (26) |
Median (IQR) age at onset of psoriasis (years) | 26 (15–42.5) |
Median (IQR) age at onset of arthritis (years) | 36.5 (26–49) |
| |
Family history of | |
Psoriasis, n (%) | 236 (49) |
PsA, n (%) | 34 (7) |
Nail involvement, n (%) | 391 (81) |
Presence of rheumatoid factor, n (%) | 81 (17) |
Ever used DMARD, n (%) | 389 (81) |
MH of dysentery, n (%) | 20 (4) |
MH conjunctivitis, n (%) | 156 (33) |
MH uveitis, n (%) | 23 (5) |
MH recurrent mouth ulcers, n (%) | 157 (33) |
MH of sexually transmitted disease, n (%) | 12 (3) |
Median (IQR) PASI | 6 (2.5–11.2) |
Median (IQR) HAQ | 1.25 (0.25–1.875) |
Median (IQR) duration of psoriasis (years) | 19 (9–33) |
Median (IQR) duration of arthritis (years) | 10 (5–19) |
| |
Onset | |
Psoriasis (>1 year) before arthritis, n (%) | 304 (63) |
Arthritis (>1 year) before psoriasis, n (%) | 72 (15) |
Psoriasis and arthritis at the same time (±1 year), n (%) | 104 (22) |
| |
Involved joint * | |
Whole cohort, median (IQR) | 10 (4.5–21) |
Presence of DIP involvement, n (%) | 310 (65) |
Mono-involved joints, n (%) | 22 (5) |
Oligo-involved joints (⩽4 joints), n (%) | 98 (20) |
Poly-involved joints (⩾5 joints), n (%) | 360 (75) |
| |
Tender joint count | |
Whole cohort, median (IQR) | 2 (0–6) |
Swollen joint count | |
Whole cohort, median (IQR) | 1 (0–4) |
| |
Damaged joints | |
Whole cohort, median (IQR) | 6 (2–15) |
DIP damaged, n (%) | 257 (54) |
Mono-damaged, n (%) | 36 (8) |
Oligo-damaged (⩽ 4 joints), n (%) | 132 (28) |
Poly-damaged joints (⩾5 joints), n (%) | 272 (57) |